Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while ...

RICHMOND, Va. (January 20, 2026) – Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) were recently awarded a $1.8 million, 3-year grant from the ...

LONDON (Reuters) - A non-surgical treatment for low-risk prostate cancer in which doctors inject a light-sensitive drug derived from deep-sea bacteria into a patient's bloodstream was shown in a trial ...

Two enzymes from the protein disulphide isomerase (PDI) family enable prostate cancer cells to grow, survive, and resist treatment. This discovery, however, could be taken as an advantage to improve ...

The man on the other end was J. Bruce Hunsicker, an Akron-based lawyer with prostate cancer who had started a foundation to raise money for research into the disease. He wanted to connect with Dr.

Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, ...

Prostate cancer is the most common cancer among men after skin cancer, according to the American Cancer Society.

New findings highlight Telomir-1’s impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways often disrupted in cancer. MIAMI, FLORIDA / ...